ReviewCancers2024

Mezigdomide-A Novel Cereblon E3 Ligase Modulator under Investigation in Relapsed/Refractory Multiple Myeloma.

Monique A Hartley-Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.